Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
SSE:603392.SS
64.14 (CNY) • At close June 17, 2025
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||
| Nettowinst
| 109.095 | 1,247.68 | 4,863.301 | 2,079.214 | 681.815 | 210.301 | 292.876 | 150.359 | 148.189 | 119.361 | 118.46 | 79.826 |
| Afschrijvingen & Amortisatie
| 300.651 | 255.614 | 151.9 | 105.276 | 84.468 | 80.508 | 71.097 | 41.946 | 26.4 | 0 | 8.379 | 3.68 |
| Uitgestelde Inkomstenbelasting
| 0 | -109.101 | 20.116 | -12.476 | 38.318 | -29.652 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verandering in Werkkapitaal
| -8.981 | -278.25 | -938.602 | -620.347 | -352.281 | -23.743 | -42.159 | -58.283 | 0 | 0 | 0 | 0 |
| Vorderingen
| 940.332 | 984.811 | -1,778.157 | -1,707.053 | -487.312 | -81.748 | 0 | 0 | 0 | 0 | 0 | 0 |
| Voorraden
| -58.184 | -218.344 | -296.472 | -222.971 | -190.678 | -49.65 | -62.31 | -44.342 | 0 | 0 | 0 | 0 |
| Crediteuren
| 0 | -935.616 | 1,115.91 | 1,322.153 | 287.391 | 137.306 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overig Werkkapitaal
| -891.129 | -109.101 | 20.116 | -12.476 | 38.318 | -29.652 | 20.151 | -13.941 | 0 | 0 | 0 | 0 |
| Overige Niet-Contante Posten
| -45.683 | 488.107 | 55.994 | 117.805 | 54.204 | 5.614 | -113.507 | 12.947 | -148.189 | -119.361 | -118.46 | -79.826 |
| Kasstroom uit Operationele Activiteiten
| 355.082 | 1,604.05 | 4,132.593 | 1,681.948 | 468.206 | 272.681 | 208.307 | 146.969 | 129.401 | 151.838 | 132.425 | 97.829 |
| Investeringsactiviteiten: | ||||||||||||
| Investeringen in Materiële Vaste Activa
| -887.35 | -1,159.672 | -929.911 | -1,047.789 | -390.437 | -162.001 | -246.062 | -214.655 | -131.265 | -77.922 | -77.426 | -82.118 |
| Netto Overnames
| 0 | 0.007 | 0.886 | 8.194 | 2.735 | 0.677 | 134.137 | 0.539 | 0.015 | 0.029 | 0.06 | 0.001 |
| Aankoop van Beleggingen
| -6,726.681 | -2,130.3 | -2,880.37 | -50.708 | -152.05 | -0.705 | -0.321 | -97.079 | -120.601 | -0.301 | -8.32 | -31.24 |
| Verkoop/verval van Beleggingen
| 6,075.201 | 2,090.001 | 1,145.494 | 73.661 | 159.036 | 11.834 | 3.058 | 3.174 | 3.938 | 4.917 | 0.148 | 0.074 |
| Overige Investeringsactiviteiten
| 35.471 | -920 | -850.001 | 2.54 | 85.318 | -48.174 | -243.331 | 6.31 | 50.174 | -152 | 14 | 7 |
| Kasstroom uit Investeringsactiviteiten
| -1,503.359 | -2,119.964 | -3,513.902 | -1,014.103 | -295.398 | -198.369 | -352.519 | -301.711 | -197.74 | -225.277 | -71.538 | -106.284 |
| Financieringsactiviteiten: | ||||||||||||
| Schuldaflossingen
| -21.152 | 38.03 | 5.245 | 162.754 | 56.599 | 0 | -197.346 | 218.346 | 0 | -31 | 0 | 0 |
| Uitgifte van Gewone Aandelen
| 0 | -22.161 | 200.168 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | -15.653 | -200.168 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| -410.181 | -904.485 | -121.408 | -108.4 | -1.654 | -1.043 | -6.294 | -4.557 | 0 | -105.338 | -2.091 | -17.268 |
| Overige Financieringsactiviteiten
| -181.411 | -26.804 | 3,443.227 | -1.569 | 324.846 | -4.134 | 174.588 | -4.396 | 105.824 | 105.445 | 80.489 | 29.703 |
| Kasstroom uit Financieringsactiviteiten
| -612.743 | -893.26 | 3,126.896 | 52.785 | 379.791 | -5.177 | -29.053 | 209.393 | 105.824 | -30.892 | 78.398 | 12.434 |
| Overige Informatie: | ||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 4.385 | 7.619 | 26.262 | -8.746 | -9.009 | 0.217 | 0.962 | -0.046 | 0.286 | 0.207 | 0.007 | -0.085 |
| Netto Kasstroomverandering
| -1,756.636 | -1,401.554 | 3,771.849 | 711.884 | 543.59 | 69.352 | -172.302 | 54.606 | 37.772 | -104.125 | 139.292 | 3.894 |
| Kaspositie aan het Einde van de Periode
| 2,027.006 | 3,783.642 | 5,185.196 | 1,413.347 | 701.463 | 157.873 | 88.521 | 260.823 | 206.217 | 168.445 | 272.571 | 133.279 |